MEPOLIZUMAB for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13,798 adverse event reports in the FDA FAERS database where MEPOLIZUMAB was used for Product used for unknown indication.
Most Reported Side Effects for MEPOLIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Asthma | 11,033 | 25.7% | 290 | 6,026 |
| Dyspnoea | 9,192 | 21.4% | 567 | 4,811 |
| Wheezing | 6,093 | 14.2% | 552 | 3,335 |
| Product dose omission issue | 5,873 | 13.7% | 88 | 957 |
| Cough | 4,577 | 10.6% | 46 | 2,079 |
| Pneumonia | 4,107 | 9.6% | 577 | 2,517 |
| Therapeutic product effect incomplete | 4,106 | 9.6% | 347 | 2,064 |
| Drug ineffective | 3,880 | 9.0% | 565 | 1,808 |
| Loss of personal independence in daily activities | 3,566 | 8.3% | 179 | 2,015 |
| Fatigue | 2,656 | 6.2% | 479 | 1,221 |
| Off label use | 2,614 | 6.1% | 788 | 938 |
| Sleep disorder due to a general medical condition | 2,574 | 6.0% | 104 | 1,406 |
| Malaise | 2,445 | 5.7% | 392 | 1,248 |
| Condition aggravated | 2,304 | 5.4% | 581 | 1,224 |
| Headache | 2,290 | 5.3% | 379 | 951 |
Other Indications for MEPOLIZUMAB
Asthma (26,352)
Eosinophilic granulomatosis with polyangiitis (1,224)
Nasal polyps (757)
Illness (372)
Hypereosinophilic syndrome (351)
Chronic obstructive pulmonary disease (291)
Chronic rhinosinusitis with nasal polyps (122)
Eosinophilia (102)
Chronic sinusitis (71)
Pulmonary vasculitis (62)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)